Congestive heart failure and Alzheimer's disease
Related Experiment Video
Updated: Jul 20, 2026

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
M Cristina Polidori1, Elena Mariani, Patrizia Mecocci
1Unit of Cognitive Frailty, Neurology Outpatient Clinic Dr. Nelles, Cologne, Germany. polidori@uni-duesseldorf.de
Insights
Congestive heart failure (CHF) is linked to cognitive impairment, increasing dementia risk in elderly patients. Early detection and management, including medication and lifestyle changes, are crucial for preventing further decline.
Area of Science:
- Gerontology
- Cardiology
- Neurology
Background:
- Rising life expectancy leads to increased prevalence of chronic illnesses like cardiovascular disease and dementia.
- Congestive heart failure (CHF) is an advanced cardiac disease frequently associated with cognitive impairment.
- The aging population will exacerbate the impact of mild cognitive impairment (MCI), Alzheimer's disease (AD), and CHF.
Purpose of the Study:
- To review the relationship between CHF and cognitive impairment.
- To explore the pathophysiology of cardiac failure in cognitive impairment and potential preventive strategies for AD.
- To emphasize the importance of early detection and management of cognitive issues in CHF patients.
Main Methods:
- Literature review focusing on CHF and cognitive impairment, particularly in the context of AD.
- Discussion of pathophysiological mechanisms linking cardiac function and cognitive decline.
- Evaluation of diagnostic and therapeutic strategies for cognitive impairment in CHF.
Main Results:
- CHF is a significant factor in cognitive impairment, with potential links to AD development.
- Preventive strategies include managing oxidative stress, using nitric oxide donors, and ensuring adequate antioxidant supply.
- Neuropsychological testing is vital for identifying early cognitive deficits and associated conditions like depression.
Conclusions:
- Systematic neuropsychological assessment in CHF patients is essential for early detection of cognitive impairment.
- Timely intervention with standard therapies (ACE inhibitors, digoxin, beta-blockers) and lifestyle modifications can mitigate cognitive decline.
- Comprehensive management plans incorporating exercise, patient education, and caregiver support are recommended.
Abstract:
The increase in average life expectancy is resulting in an increasing prevalence of major invalidating illnesses, such as cardiovascular disease and dementia. Congestive heart failure (CHF) is a chronic, progressive disease representing the advanced stage of cardiac illnesses. Cognitive impairment is known to be a frequent feature of CHF patients. The epidemiologic pictures of mild cognitive impairment (MCI), Alzheimer's disease (AD) and CHF are predicted to worsen with the demographic expansion of the elderly population. Nevertheless, there has been little structured research on cognitive impairment in patients with CHF. This is unfortunate not only because CHF is the leading cause of hospitalization in the elderly and a leading cause of disability and death, but also for important clinical and socioeconomic implications including those related to comorbidity in advanced age and the need to early detect factors which may precipitate the conversion of MCI to AD. In this review, several aspects of the role of CHF in cognitive impairment are evaluated. Owing to the lack of studies focusing on CHF in AD, the pathophysiology of cardiac failure in cognitive impairment is addressed in light of possible preventive strategies against the onset of AD. These include prevention of oxygen radical and peroxynitrite production, supplementation of nitric oxide (NO) donors, as well as the achievement of an adequate antioxidant supply, better if obtained with a targeted and individualized nutritional approach. A systematic neuropsychologic testing of older patients with heart failure is to identify those with early cognitive impairment and promptly establish traditional therapies such as angiotensin converting enzyme (ACE) inhibitors, digoxin or beta-blockers. The neuropsychologic assessment in CHF patients is also fundamental to disclose conditions potentially favoring the onset of cognitive impairment such as depression. Finally, management schemes should include exercise training programs as well as patient and caregiver education.
Related Concept Videos
Alzheimer Disease l: Introduction
Dementia l: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Heart Failure III: Clinical Manifestations
